Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies

Objectives: Chronic cerebrospinal venous insufficiency (CCSVI) has recently been implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis of case–control studies investigates the association of CCSVI with MS. Methods: Through Medline, EMBASE and Cochrane database s...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic Advances in Neurological Disorders 2014-03, Vol.7 (2), p.114-136
Main Authors: Tsivgoulis, Georgios, Sergentanis, Theodoros N., Chan, Andrew, Voumvourakis, Konstantinos, Triantafyllou, Nikos, Psaltopoulou, Theodora, Gold, Ralf, Krogias, Christos
Format: Article
Language:English
Subjects:
Reviews
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c500t-43b2d04cc5bdf198c6b48db9dc1d2079c2401d87b164939b3044794a152d71b93
cites cdi_FETCH-LOGICAL-c500t-43b2d04cc5bdf198c6b48db9dc1d2079c2401d87b164939b3044794a152d71b93
container_end_page 136
container_issue 2
container_start_page 114
container_title Therapeutic Advances in Neurological Disorders
container_volume 7
creator Tsivgoulis, Georgios
Sergentanis, Theodoros N.
Chan, Andrew
Voumvourakis, Konstantinos
Triantafyllou, Nikos
Psaltopoulou, Theodora
Gold, Ralf
Krogias, Christos
description Objectives: Chronic cerebrospinal venous insufficiency (CCSVI) has recently been implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis of case–control studies investigates the association of CCSVI with MS. Methods: Through Medline, EMBASE and Cochrane database searches, case–control ultrasound studies comparing CCSVI frequency among patients with MS and healthy controls were identified. Results: We identified 19 eligible studies including 1250 patients with MS and 899 healthy controls. The pooled analysis showed that CCSVI was associated with MS [odds ratio (OR) 8.35; 95% confidence interval (CI) 3.44–20.31; p < 0.001) with considerable heterogeneity across studies (I2 = 80.1%). This association was substantially attenuated in sensitivity analyses excluding studies that were carried out by the group that originally described CCSVI, included investigators who had also been involved in publications advocating endovascular procedures for CCSVI treatment, or were conducted in Italy. Our most conservative sensitivity analysis combining different exclusion criteria yielded no association of CCSVI with MS (OR 1.35; 95% CI 0.62–2.93; p = 0.453) without any heterogeneity (I2 = 0%). Conclusion: There is considerable heterogeneity across different case–control studies evaluating the association of CCSVI and MS. The greatest factor contributing to this heterogeneity appears to be the involvement of investigators in other publications supporting endovascular procedures as a novel MS treatment.
doi_str_mv 10.1177/1756285613499425
format article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e6c6af888b8f4b879e2a97903bb5c2be</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1756285613499425</sage_id><doaj_id>oai_doaj_org_article_e6c6af888b8f4b879e2a97903bb5c2be</doaj_id><sourcerecordid>1540108887</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-43b2d04cc5bdf198c6b48db9dc1d2079c2401d87b164939b3044794a152d71b93</originalsourceid><addsrcrecordid>eNp1kbtuFDEUhkcIREKgp0IuaQZsj8cXCiS0IhApEg3Uli9ndr2asRd7ZqVNxTvwhjxJHDasCBKVrXP-853L3zQvCX5DiBBvieg5lT0nHVOK0f5Rc34Xaqnk7PHp3_Oz5lkpW4w5FQw_bc4o66WQVJw3N6tNTjE45CCDzansQjQj2kNMS0EhlmUYggsQ3QGZ6NG0jHPYjYCKG6HKQ3mHDHJp2mXYQCxhD2iC2bSmYg41jdKAnCnw68dPl-Kc04jKvPgA5XnzZDBjgRf370Xz7fLj19Xn9vrLp6vVh-vW9RjPLess9Zg511s_ECUdt0x6q7wjnmKhHGWYeCks4Ux1ynaYMaGYIT31gljVXTRXR65PZqt3OUwmH3QyQf8OpLzWJs-h7qOBO24GKaWVA7NSKKBGCYU7a3tHLVTW-yNrt9gJvIO6kRkfQB9mYtjoddrrTnVUcF4Br-8BOX1foMx6CsXBOJoI9eKa9HUbXCcQVYqPUlfvXDIMpzYE6zv79b_215JXf493KvjjdxW0R0Exa9DbtORqU_k_8BbOtLxL</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1540108887</pqid></control><display><type>article</type><title>Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies</title><source>SAGE Open Access</source><creator>Tsivgoulis, Georgios ; Sergentanis, Theodoros N. ; Chan, Andrew ; Voumvourakis, Konstantinos ; Triantafyllou, Nikos ; Psaltopoulou, Theodora ; Gold, Ralf ; Krogias, Christos</creator><creatorcontrib>Tsivgoulis, Georgios ; Sergentanis, Theodoros N. ; Chan, Andrew ; Voumvourakis, Konstantinos ; Triantafyllou, Nikos ; Psaltopoulou, Theodora ; Gold, Ralf ; Krogias, Christos</creatorcontrib><description>Objectives: Chronic cerebrospinal venous insufficiency (CCSVI) has recently been implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis of case–control studies investigates the association of CCSVI with MS. Methods: Through Medline, EMBASE and Cochrane database searches, case–control ultrasound studies comparing CCSVI frequency among patients with MS and healthy controls were identified. Results: We identified 19 eligible studies including 1250 patients with MS and 899 healthy controls. The pooled analysis showed that CCSVI was associated with MS [odds ratio (OR) 8.35; 95% confidence interval (CI) 3.44–20.31; p &lt; 0.001) with considerable heterogeneity across studies (I2 = 80.1%). This association was substantially attenuated in sensitivity analyses excluding studies that were carried out by the group that originally described CCSVI, included investigators who had also been involved in publications advocating endovascular procedures for CCSVI treatment, or were conducted in Italy. Our most conservative sensitivity analysis combining different exclusion criteria yielded no association of CCSVI with MS (OR 1.35; 95% CI 0.62–2.93; p = 0.453) without any heterogeneity (I2 = 0%). Conclusion: There is considerable heterogeneity across different case–control studies evaluating the association of CCSVI and MS. The greatest factor contributing to this heterogeneity appears to be the involvement of investigators in other publications supporting endovascular procedures as a novel MS treatment.</description><identifier>ISSN: 1756-2856</identifier><identifier>ISSN: 1756-2864</identifier><identifier>EISSN: 1756-2864</identifier><identifier>DOI: 10.1177/1756285613499425</identifier><identifier>PMID: 24587827</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Reviews</subject><ispartof>Therapeutic Advances in Neurological Disorders, 2014-03, Vol.7 (2), p.114-136</ispartof><rights>The Author(s), 2013</rights><rights>The Author(s), 2013 2013 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-43b2d04cc5bdf198c6b48db9dc1d2079c2401d87b164939b3044794a152d71b93</citedby><cites>FETCH-LOGICAL-c500t-43b2d04cc5bdf198c6b48db9dc1d2079c2401d87b164939b3044794a152d71b93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932766/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932766/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,313,314,727,780,784,792,885,21966,27853,27922,27924,27925,44945,45333,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/1756285613499425?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24587827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsivgoulis, Georgios</creatorcontrib><creatorcontrib>Sergentanis, Theodoros N.</creatorcontrib><creatorcontrib>Chan, Andrew</creatorcontrib><creatorcontrib>Voumvourakis, Konstantinos</creatorcontrib><creatorcontrib>Triantafyllou, Nikos</creatorcontrib><creatorcontrib>Psaltopoulou, Theodora</creatorcontrib><creatorcontrib>Gold, Ralf</creatorcontrib><creatorcontrib>Krogias, Christos</creatorcontrib><title>Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies</title><title>Therapeutic Advances in Neurological Disorders</title><addtitle>Ther Adv Neurol Disord</addtitle><description>Objectives: Chronic cerebrospinal venous insufficiency (CCSVI) has recently been implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis of case–control studies investigates the association of CCSVI with MS. Methods: Through Medline, EMBASE and Cochrane database searches, case–control ultrasound studies comparing CCSVI frequency among patients with MS and healthy controls were identified. Results: We identified 19 eligible studies including 1250 patients with MS and 899 healthy controls. The pooled analysis showed that CCSVI was associated with MS [odds ratio (OR) 8.35; 95% confidence interval (CI) 3.44–20.31; p &lt; 0.001) with considerable heterogeneity across studies (I2 = 80.1%). This association was substantially attenuated in sensitivity analyses excluding studies that were carried out by the group that originally described CCSVI, included investigators who had also been involved in publications advocating endovascular procedures for CCSVI treatment, or were conducted in Italy. Our most conservative sensitivity analysis combining different exclusion criteria yielded no association of CCSVI with MS (OR 1.35; 95% CI 0.62–2.93; p = 0.453) without any heterogeneity (I2 = 0%). Conclusion: There is considerable heterogeneity across different case–control studies evaluating the association of CCSVI and MS. The greatest factor contributing to this heterogeneity appears to be the involvement of investigators in other publications supporting endovascular procedures as a novel MS treatment.</description><subject>Reviews</subject><issn>1756-2856</issn><issn>1756-2864</issn><issn>1756-2864</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp1kbtuFDEUhkcIREKgp0IuaQZsj8cXCiS0IhApEg3Uli9ndr2asRd7ZqVNxTvwhjxJHDasCBKVrXP-853L3zQvCX5DiBBvieg5lT0nHVOK0f5Rc34Xaqnk7PHp3_Oz5lkpW4w5FQw_bc4o66WQVJw3N6tNTjE45CCDzansQjQj2kNMS0EhlmUYggsQ3QGZ6NG0jHPYjYCKG6HKQ3mHDHJp2mXYQCxhD2iC2bSmYg41jdKAnCnw68dPl-Kc04jKvPgA5XnzZDBjgRf370Xz7fLj19Xn9vrLp6vVh-vW9RjPLess9Zg511s_ECUdt0x6q7wjnmKhHGWYeCks4Ux1ynaYMaGYIT31gljVXTRXR65PZqt3OUwmH3QyQf8OpLzWJs-h7qOBO24GKaWVA7NSKKBGCYU7a3tHLVTW-yNrt9gJvIO6kRkfQB9mYtjoddrrTnVUcF4Br-8BOX1foMx6CsXBOJoI9eKa9HUbXCcQVYqPUlfvXDIMpzYE6zv79b_215JXf493KvjjdxW0R0Exa9DbtORqU_k_8BbOtLxL</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Tsivgoulis, Georgios</creator><creator>Sergentanis, Theodoros N.</creator><creator>Chan, Andrew</creator><creator>Voumvourakis, Konstantinos</creator><creator>Triantafyllou, Nikos</creator><creator>Psaltopoulou, Theodora</creator><creator>Gold, Ralf</creator><creator>Krogias, Christos</creator><general>SAGE Publications</general><general>SAGE Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140301</creationdate><title>Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies</title><author>Tsivgoulis, Georgios ; Sergentanis, Theodoros N. ; Chan, Andrew ; Voumvourakis, Konstantinos ; Triantafyllou, Nikos ; Psaltopoulou, Theodora ; Gold, Ralf ; Krogias, Christos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-43b2d04cc5bdf198c6b48db9dc1d2079c2401d87b164939b3044794a152d71b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Reviews</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsivgoulis, Georgios</creatorcontrib><creatorcontrib>Sergentanis, Theodoros N.</creatorcontrib><creatorcontrib>Chan, Andrew</creatorcontrib><creatorcontrib>Voumvourakis, Konstantinos</creatorcontrib><creatorcontrib>Triantafyllou, Nikos</creatorcontrib><creatorcontrib>Psaltopoulou, Theodora</creatorcontrib><creatorcontrib>Gold, Ralf</creatorcontrib><creatorcontrib>Krogias, Christos</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Therapeutic Advances in Neurological Disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Tsivgoulis, Georgios</au><au>Sergentanis, Theodoros N.</au><au>Chan, Andrew</au><au>Voumvourakis, Konstantinos</au><au>Triantafyllou, Nikos</au><au>Psaltopoulou, Theodora</au><au>Gold, Ralf</au><au>Krogias, Christos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies</atitle><jtitle>Therapeutic Advances in Neurological Disorders</jtitle><addtitle>Ther Adv Neurol Disord</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>7</volume><issue>2</issue><spage>114</spage><epage>136</epage><pages>114-136</pages><issn>1756-2856</issn><issn>1756-2864</issn><eissn>1756-2864</eissn><abstract>Objectives: Chronic cerebrospinal venous insufficiency (CCSVI) has recently been implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis of case–control studies investigates the association of CCSVI with MS. Methods: Through Medline, EMBASE and Cochrane database searches, case–control ultrasound studies comparing CCSVI frequency among patients with MS and healthy controls were identified. Results: We identified 19 eligible studies including 1250 patients with MS and 899 healthy controls. The pooled analysis showed that CCSVI was associated with MS [odds ratio (OR) 8.35; 95% confidence interval (CI) 3.44–20.31; p &lt; 0.001) with considerable heterogeneity across studies (I2 = 80.1%). This association was substantially attenuated in sensitivity analyses excluding studies that were carried out by the group that originally described CCSVI, included investigators who had also been involved in publications advocating endovascular procedures for CCSVI treatment, or were conducted in Italy. Our most conservative sensitivity analysis combining different exclusion criteria yielded no association of CCSVI with MS (OR 1.35; 95% CI 0.62–2.93; p = 0.453) without any heterogeneity (I2 = 0%). Conclusion: There is considerable heterogeneity across different case–control studies evaluating the association of CCSVI and MS. The greatest factor contributing to this heterogeneity appears to be the involvement of investigators in other publications supporting endovascular procedures as a novel MS treatment.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>24587827</pmid><doi>10.1177/1756285613499425</doi><tpages>23</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1756-2856
ispartof Therapeutic Advances in Neurological Disorders, 2014-03, Vol.7 (2), p.114-136
issn 1756-2856
1756-2864
1756-2864
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e6c6af888b8f4b879e2a97903bb5c2be
source SAGE Open Access
subjects Reviews
title Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A14%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20cerebrospinal%20venous%20insufficiency%20and%20multiple%20sclerosis:%20a%20comprehensive%20meta-analysis%20of%20case%E2%80%93control%20studies&rft.jtitle=Therapeutic%20Advances%20in%20Neurological%20Disorders&rft.au=Tsivgoulis,%20Georgios&rft.date=2014-03-01&rft.volume=7&rft.issue=2&rft.spage=114&rft.epage=136&rft.pages=114-136&rft.issn=1756-2856&rft.eissn=1756-2864&rft_id=info:doi/10.1177/1756285613499425&rft_dat=%3Cproquest_AFRWT%3E1540108887%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c500t-43b2d04cc5bdf198c6b48db9dc1d2079c2401d87b164939b3044794a152d71b93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1540108887&rft_id=info:pmid/24587827&rft_sage_id=10.1177_1756285613499425&rfr_iscdi=true